Related Experiment Video
Updated: May 25, 2026
11:20
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
Published on: March 29, 2018
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
Ge Zhang1, Baosheng Guo, Heng Wu
1Musculoskeletal Research Laboratory, Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, China.
Nature Medicine
|January 31, 2012
Summary
Researchers developed a novel targeted delivery system using (AspSerSer)(6)-liposomes to deliver osteogenic small interfering RNAs (siRNAs). This approach successfully promoted bone formation and enhanced bone mass in rats, offering a promising therapy for metabolic bone disorders.
Area of Science:
- Biomaterials Science
- Molecular Biology
- Regenerative Medicine
Background:
- Metabolic skeletal disorders impairing bone formation present significant clinical challenges.
- Targeted delivery of therapeutic agents to osteogenic cells is crucial for treating these conditions.
- Small interfering RNAs (siRNAs) offer a potential strategy to silence bone-formation-inhibitory genes.
Purpose of the Study:
- To develop and evaluate a targeted delivery system for siRNAs to osteogenic cells.
- To assess the efficacy of delivering an siRNA targeting casein kinase-2 interacting protein-1 (Plekho1) for promoting bone formation.
Main Methods:
- Development of dioleoyl trimethylammonium propane (DOTAP)-based cationic liposomes functionalized with (AspSerSer)(6) peptide sequences for targeted delivery.
- Encapsulation of an siRNA targeting Plekho1 within the liposome system.
- In vivo systemic administration of the siRNA-loaded liposomes in rats (both healthy and osteoporotic models).
- Evaluation of siRNA biodistribution, Plekho1 gene silencing, bone formation, micro-architecture, and bone mass using bioimaging and other analyses.
Main Results:
- The (AspSerSer)(6)-liposome system demonstrated selective enrichment of siRNAs in osteogenic cells at bone-formation sites.
- Systemic delivery of Plekho1 siRNA effectively depleted Plekho1 expression in target cells.
- Significant promotion of bone formation, enhancement of bone micro-architecture, and increase in bone mass were observed in treated rats.
- The delivery system proved effective in both healthy and osteoporotic rat models.
Conclusions:
- The (AspSerSer)(6)-liposome system is a highly effective targeted delivery vehicle for RNA interference (RNAi) therapeutics.
- This approach shows significant potential for bone anabolic therapy in treating metabolic skeletal disorders.
- Targeted delivery of Plekho1 siRNA via this system represents a promising strategy for bone regeneration.
More Related Videos
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...